FDA-Drug2017-07-26Class III
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56
Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.
Sold states
Nationwide in the USA
Affected count
196275 bottles
Manufactured in
1090 Horsham Rd, N/A, North Wales, PA, United States
Products
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per Bottle, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5721-56
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0984-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief